//
Dapagliflozin for treating chronic heart failure with reduced ejection fraction
Age-Related Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction
Heart Failure With Recovered Left Ventricular Ejection Fraction: JACC Scientific Expert Panel
Fluid Volume Overload and Congestion in Heart Failure: Time to Reconsider Pathophysiology and How Volume Is Assessed
Frailty Is Intertwined With Heart Failure: Mechanisms, Prevalence, Prognosis, Assessment, and Management
Ejection Fraction Pros and Cons: JACC State-of-the-Art Review
A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: rationale, design, and baseline patient characteristics
Association of Left Ventricular Systolic Function With Incident Heart Failure in Late Life